Apellis Pharmaceuticals Inc
NASDAQ:APLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
S
|
Star7 SpA
MIL:STAR7
|
IT |
|
Ibersol SGPS SA
F:L34
|
PT |
|
Paladin Energy Ltd
TSX:PDN
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APLS's stock price target?
Not Available
APLS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
10%
The compound annual growth rate for Revenue over the next 8 years is 10%.
What is the Gross Profit forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
40%
The compound annual growth rate for Operating Income over the next 8 years is 40%.
What is the Pre-Tax Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
55%
The compound annual growth rate for Net Income over the next 8 years is 55%.
